These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 2123039

  • 1. Fluvoxamine in the treatment of tricyclic-resistant depression.
    White K, Wykoff W, Tynes LL, Schneider L, Zemansky M.
    Psychiatr J Univ Ott; 1990 Sep; 15(3):156-8. PubMed ID: 2123039
    [Abstract] [Full Text] [Related]

  • 2. The role of neuropharmacologic selectivity in antidepressant action: fluvoxamine versus desipramine.
    Nathan RS, Perel JM, Pollock BG, Kupfer DJ.
    J Clin Psychiatry; 1990 Sep; 51(9):367-72. PubMed ID: 2120201
    [Abstract] [Full Text] [Related]

  • 3. A double-blind placebo-controlled study of fluvoxamine and imipramine in depression.
    Dominguez RA, Goldstein BJ, Jacobson AF, Steinbook RM.
    J Clin Psychiatry; 1985 Mar; 46(3):84-7. PubMed ID: 3918993
    [Abstract] [Full Text] [Related]

  • 4. A double-blind, placebo-controlled trial of fluvoxamine versus imipramine in outpatients with major depression.
    March JS, Kobak KA, Jefferson JW, Mazza J, Greist JH.
    J Clin Psychiatry; 1990 May; 51(5):200-2. PubMed ID: 2110560
    [Abstract] [Full Text] [Related]

  • 5. A double-blind comparison of fluvoxamine, desipramine and placebo in outpatients with depression.
    Roth D, Mattes J, Sheehan KH, Sheehan DV.
    Prog Neuropsychopharmacol Biol Psychiatry; 1990 May; 14(6):929-39. PubMed ID: 2126144
    [Abstract] [Full Text] [Related]

  • 6. Randomized double-blind study of fluvoxamine and maprotiline in treatment of depression.
    de Jonghe F, Swinkels J, Tuynman-Qua H.
    Pharmacopsychiatry; 1991 Jan; 24(1):21-7. PubMed ID: 1901418
    [Abstract] [Full Text] [Related]

  • 7. Treatment of major affective disorder with fluvoxamine.
    Lapierre YD, Browne M, Horn E, Oyewumi LK, Sarantidis D, Roberts N, Badoe K, Tessier P.
    J Clin Psychiatry; 1987 Feb; 48(2):65-8. PubMed ID: 3100510
    [Abstract] [Full Text] [Related]

  • 8. Controlled cross-over study of a 5-HT uptake inhibiting and an NA uptake inhibiting antidepressant.
    Aberg A.
    Acta Psychiatr Scand Suppl; 1981 Feb; 290():244-55. PubMed ID: 6452794
    [Abstract] [Full Text] [Related]

  • 9. A Belgian multicentre study of fluvoxamine in depressive outpatients.
    Brasseur R, Van Moffaert M, Mesotten F, Ansseau M, Uytdenhoef P, Bartholome F.
    Acta Psychiatr Belg; 1985 Feb; 85(5):636-43. PubMed ID: 3937441
    [Abstract] [Full Text] [Related]

  • 10. Serotonin reuptake inhibition vs. norepinephrine reuptake inhibition: a double-blind differential-therapeutic study with fluvoxamine and oxaprotiline in endogenous and neurotic depressives.
    Emrich HM, Berger M, Riemann D, von Zerssen D.
    Pharmacopsychiatry; 1987 Mar; 20(2):60-3. PubMed ID: 3108909
    [Abstract] [Full Text] [Related]

  • 11. Flupenthixol and fluvoxamine in mild to moderate depression: a comparison in general practice.
    Hamilton BA, Jones PG, Hoda AN, Keane PM, Majid I, Zaidi SI.
    Pharmatherapeutica; 1989 Mar; 5(5):292-7. PubMed ID: 2501801
    [Abstract] [Full Text] [Related]

  • 12. Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Comparison of fluvoxamine and desipramine.
    Goodman WK, Price LH, Delgado PL, Palumbo J, Krystal JH, Nagy LM, Rasmussen SA, Heninger GR, Charney DS.
    Arch Gen Psychiatry; 1990 Jun; 47(6):577-85. PubMed ID: 2112374
    [Abstract] [Full Text] [Related]

  • 13. Response to total sleep deprivation before and during treatment with fluvoxamine or maprotiline in patients with major depression--results of a double-blind study.
    Kasper S, Voll G, Vieira A, Kick H.
    Pharmacopsychiatry; 1990 May; 23(3):135-42. PubMed ID: 2115680
    [Abstract] [Full Text] [Related]

  • 14. Fluvoxamine, imipramine, and placebo in the treatment of depressed outpatients: effects on depression.
    Lydiard RB, Laird LK, Morton WA, Steele TE, Kellner C, Laraia MT, Ballenger JC.
    Psychopharmacol Bull; 1989 May; 25(1):68-70. PubMed ID: 2505304
    [No Abstract] [Full Text] [Related]

  • 15. Alprazolam: an antidepressant? Alprazolam, desipramine, and an alprazolam-desipramine combination in the treatment of adult depressed outpatients.
    Fawcett J, Edwards JH, Kravitz HM, Jeffriess H.
    J Clin Psychopharmacol; 1987 Oct; 7(5):295-310. PubMed ID: 3316312
    [Abstract] [Full Text] [Related]

  • 16. Fluoxetine and desipramine in major depressive disorder.
    Bowden CL, Schatzberg AF, Rosenbaum A, Contreras SA, Samson JA, Dessain E, Sayler M.
    J Clin Psychopharmacol; 1993 Oct; 13(5):305-11. PubMed ID: 8227488
    [Abstract] [Full Text] [Related]

  • 17. Response to desipramine treatment in adolescent major depression.
    Boulos C, Kutcher S, Marton P, Simeon J, Ferguson B, Roberts N.
    Psychopharmacol Bull; 1991 Oct; 27(1):59-65. PubMed ID: 1862207
    [Abstract] [Full Text] [Related]

  • 18. A double-blind comparison of fluvoxamine and dothiepin in the treatment of major affective disorder.
    Mullin JM, Pandita-Gunawardena VR, Whitehead AM.
    Br J Clin Pract; 1988 Feb; 42(2):51-5. PubMed ID: 3140864
    [No Abstract] [Full Text] [Related]

  • 19. A double-blind clinical trial of fluvoxamine and imipramine in patients with primary depression.
    Guy W, Wilson WH, Ban TA, King DL, Manov G, Fjetland OK.
    Psychopharmacol Bull; 1984 Feb; 20(1):73-8. PubMed ID: 6425916
    [No Abstract] [Full Text] [Related]

  • 20. A double-blind comparison of clovoxamine and amitriptyline in the treatment of depressed outpatients.
    Gelenberg AJ, Wojcik JD, Newell C, Lamping DL, Spring B.
    J Clin Psychopharmacol; 1985 Feb; 5(1):30-4. PubMed ID: 3882774
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.